22 Jun 2021 BioAxone BioSciences Announces License of Cerebral Cavernous Malformations Drug Candidate BA-1049 and Portfolio of Rho Kinase Inhibitors to Neurelis Press Releases BOSTON–(
22 Jun 2021 LEO Pharma announces European Commission approval of Adtralza® (tralokinumab) as the first and only treatment specifically targeting IL-13 for adults with moderate-to-severe atopic dermatitis Press Releases BALLERUP, Denmark–(
22 Jun 2021 ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of “ultra long-acting” medicines for HIV Press Releases LONDON & SAN DIEGO–(
22 Jun 2021 A Prospective Study in More Than 1,000 Osteoporosis Patients Concluded That Binosto® (Buffered Soluble Alendronate) May Increase Patient Satisfaction, Long-Term Adherence and Therefore Efficacy Press Releases FREIENBACH, Switzerland–(
22 Jun 2021 LetsGetChecked to Provide Next-Generation Sequencing on Positive COVID-19 Tests To Determine Virus Variants Press Releases NEW YORK–(
22 Jun 2021 Merck Announces Phase 3 KEYNOTE-826 Trial Met Dual Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Patients With Persistent, Recurrent or Metastatic Cervical Cancer Press Releases KENILWORTH, N.J.–(
22 Jun 2021 Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics Press Releases BOSTON & SAN FRANCISCO–(
22 Jun 2021 Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics Launch New CAR T-Cell Company Press Releases CAMBRIDGE, Mass.–(
21 Jun 2021 A History of Pharmaceutical Innovation In Mexico from 1950 to 2020 Press Releases Innovation in healthcare over the past 70 years led to a dramatic increase in average life expectancy in Mexico – which is…
